ASTENOSE

Welcome to the Brand page for “ASTENOSE”, which is offered here for Pharmaceutical composition for the treatment of cardiovascular disease, immune disfunction, inflammation, cancers, infectious disease, and viral disease;aste - nose;.

Its status is currently believed to be active. Its class is unavailable. “ASTENOSE” is believed to be currently owned by “Glycomed Incorporated”.


Owner:
GLYCOMED INCORPORATED
Owner Details
Description:
Pharmaceutical composition for the treatment of cardiovascular disease, immune disfunction, inflammation, cancers, infectious disease, and viral disease;ASTE - NOSE;
Categories: PHARMACEUTICAL COMPOSITION TREATMENT